Home » Topics » BioWorld Science

BioWorld Science
RSS

Company Profile: Progenics

Nov. 28, 1997

AutoImmune: Q3 1997 highlights

Nov. 28, 1997

Company Profile: Oxigene

Nov. 28, 1997

Company Profile: LeukoSite

Nov. 28, 1997

SmithKline Beecham and Cephalon terminate calpain inhibitor collaboration

Nov. 27, 1997

Bronchodilating mechanism of PDE IV inhibitors investigated using CP-80633

Nov. 27, 1997

First anticancer monoclonal antibody approved by FDA

Nov. 27, 1997

FACT study results reported

Nov. 27, 1997

FDA clears Zomig

Nov. 27, 1997

Launch of Ligand/Lilly metabolic disease alliance

Nov. 27, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...